Exact Mass: 612.3199
Exact Mass Matches: 612.3199
Found 340 metabolites which its exact mass value is equals to given mass value 612.3199
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(24E)-3beta,15alpha,22S-Triacetoxylanosta-7,9(11),24-trien-26-oic acid
Metabolite of Ganoderma lucidum (reishi). (24E)-3beta,15alpha,22S-Triacetoxylanosta-7,9(11),24-trien-26-oic acid is found in mushrooms. Ganoderic acid T is found in mushrooms. Ganoderic acid T is a constituent of the cultured mycelium of Ganoderma lucidum (reishi)
[D-Met2, Pro5]-enkephalinamide
(E)-4-[[(1R)-2-[[(2R)-2-(2-Adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobut-2-enoic acid
Cyclopyrrhoxanthin
Pyrrhoxanthin 5,8-furanoxide
3-[8-butan-2-yl-14-(1H-indol-3-ylmethyl)-5-methyl-11-(2-methylpropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propanoic acid
3beta,15alpha,22S-Triacetoxylanosta-7,9(11),24E-trien-26-oic acid
(3alpha)-3-[(6-O-beta-apiofuranosyl-beta-Dglucofuranosyl)oxy]cleroda-4(18),13-diene-15-oic acid-15,16-lactone|4-{2-{(1S,2R,4aR,6R,8aR)-6-[(6-O-D-apio-beta-D-furanosyl-beta-D-glucopyranosyl)oxy]decahydro-1,2,4a-trimethyl-5-methylenenaphthalen-1-yl}ethyl}furan-2(5H)-one|caseariaside D
4-(7-hydroxy-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-1-ylmethyl)-5-[4-(7-hydroxy-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-1-ylmethyl)-phenoxy]-benzene-1,2-diol|Magnolamin
2-O-beta-D-glucopyranosyl-4-O-beta-D-glucopyranosyl-3,5-bis(3-methyl-2-butenyl)-methyl-17-benzoate|liparisglycoside A
dryobalanolide triacetate|triacetyl dryobalanolide
limnantheoside A
all-trans-(9Z,11Z)-(3R,3S,5R,6R)-Pyrrhoxanthin|Pyrrhoxanthin
19-O-[beta-D-apiofuranosyl(1->2)-beta-D-glucopyranosyl]-3,14-dideoxyandrographolide
Di-Ac,di-Me ester-(2alpha,3beta)-2,3-Dihydroxy-12,18-oleanadiene-24,28-dioic acid
(25R)-5beta-spirostane-1beta,2beta,3beta,4beta,5beta-pentol 1-O-beta-D-xylopyranoside
Phe Tyr Lys Arg
Asp His Arg Trp
Asp His Trp Arg
Asp Arg His Trp
Asp Arg Trp His
Asp Trp His Arg
Asp Trp Arg His
Phe Lys Arg Tyr
Phe Lys Tyr Arg
Phe Gln Arg Tyr
Phe Gln Tyr Arg
Phe Arg Lys Tyr
Phe Arg Gln Tyr
Phe Arg Tyr Lys
Phe Arg Tyr Gln
Phe Tyr Gln Arg
Phe Tyr Arg Lys
Phe Tyr Arg Gln
His Asp Arg Trp
His Asp Trp Arg
His Arg Asp Trp
His Arg Trp Asp
His Trp Asp Arg
His Trp Arg Asp
Lys Phe Arg Tyr
Lys Phe Tyr Arg
Lys Arg Phe Tyr
Lys Arg Tyr Phe
Lys Tyr Phe Arg
Lys Tyr Arg Phe
Gln Phe Arg Tyr
Gln Phe Tyr Arg
Gln Arg Phe Tyr
Gln Arg Tyr Phe
Gln Tyr Phe Arg
Gln Tyr Arg Phe
Arg Asp His Trp
Arg Asp Trp His
Arg Phe Lys Tyr
Arg Phe Gln Tyr
Arg Phe Tyr Lys
Arg Phe Tyr Gln
Arg His Asp Trp
Arg His Trp Asp
Arg Lys Phe Tyr
Arg Lys Tyr Phe
Arg Gln Phe Tyr
Arg Gln Tyr Phe
Arg Trp Asp His
Arg Trp His Asp
Arg Tyr Phe Lys
Arg Tyr Phe Gln
Arg Tyr Lys Phe
Arg Tyr Gln Phe
Trp Asp His Arg
Trp Asp Arg His
Trp His Asp Arg
Trp His Arg Asp
Trp Arg Asp His
Trp Arg His Asp
Tyr Phe Lys Arg
Tyr Phe Gln Arg
Tyr Phe Arg Lys
Tyr Phe Arg Gln
Tyr Lys Phe Arg
Tyr Lys Arg Phe
Tyr Gln Phe Arg
Tyr Gln Arg Phe
Tyr Arg Phe Lys
Tyr Arg Phe Gln
Tyr Arg Lys Phe
Tyr Arg Gln Phe
pyrrhoxanthin
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
(3a,5b,7b,12a)-(1,3-dihydro-5-nitro-1,3-dioxo-2H-isoindol-2-yl)methyl ester-3,7,12-trihydroxy-Cholan
3b,15a,22S-Triacetoxylanosta-7,9(11),24E-trien-26-Oic acid
Lasalocid Sodium
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic D049990 - Membrane Transport Modulators D007476 - Ionophores Lasalocid sodium (Lasalocid-A sodium) is an antibacterial agent.
Substance P (7-11)
D018377 - Neurotransmitter Agents > D015320 - Tachykinins Substance P (7-11) is a C-terminal fragment of Substance P which can cause an increase in the intracellular calcium concentration. Substance P (7-11) is a C-terminal fragment of Substance P which can cause an increase in the intracellular calcium concentration.
1,3,3-trimethyl-2-[2-[2-phenyl-3-[2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]cyclohex-2-en-1-ylidene]ethylidene]indole,tetrafluoroborate
4-o-benzyl-3-(-)-carboxymenthyl-1,2:5,6-di-o-cyclohexylidene-l-myo-inositol
[2,4,6-Triisopropyl-phenylsulfonyl-L-[3-amidino-phenylalanine]]-piperazine-N-beta-alanine
3-[(11R,12R,21S,22S)-11-ethyl-4-hydroxy-16-(1-hydroxyethyl)-3-methoxycarbonyl-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,13,15(24),16,18,20(23)-decaen-22-yl]propanoic acid
3-[(21S,22S)-12-(dihydroxymethyl)-11,26-diethyl-4-hydroxy-16-[(1R)-1-hydroxyethyl]-17,19,21-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
1-cyclohexyl-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
1-(1,3-benzodioxol-5-yl)-3-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
N-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
N-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide
1-(1,3-benzodioxol-5-yl)-3-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea
[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (Z)-nonadec-9-enoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] nonanoate
[2-Hexanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] hexanoate
[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] heptanoate
[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] octanoate
[1-Acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] decanoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-tridec-9-enoate
[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-pentadec-9-enoate
[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate
2-[[3-acetyloxy-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-butanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-hexanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
1-(9Z-nonadecenoyl)-glycero-3-phospho-(1-myo-inositol)
MGDG(25:10)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
JWG-071
JWG-071 is the kinase-selective chemical probe for ERK5. JWG-071 inhibits ERK5 and LRRK2 with IC50 values of 88nM and 109 nM, respectively[1].
(2s)-n-(5-carbamimidamido-1-oxopentan-2-yl)-2-{[(2r)-2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-4-(4-hydroxyphenyl)butylidene]amino}-4-methylpentanimidic acid
(1r,2r,3r,4s,5r,6s,7s,8r,10s,11s,14r)-5,11-bis(acetyloxy)-14-(butanoyloxy)-6,10-dihydroxy-3-isopropyl-6,10,14-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-4-yl butanoate
7,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-[5-oxo-6-(propan-2-ylidene)oxan-3-yl]-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
1-[(1r,9s,10r,11r,12e,17s)-12-ethylidene-10-[(1r,13s,19s,21r)-14-ethylidene-10-oxa-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,11-tetraen-9-yl]-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6-trien-8-yl]ethanone
(6r,7s,8r,12r,19s,20r)-17-methoxy-7,15,19,20-tetramethyl-18-oxo-10-{[(2s,4s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5,11-trioxapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icos-16-en-7-yl acetate
5,6,11-trihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-7-oxo-3-oxapentacyclo[9.5.0.0²,⁴.0⁶,¹⁰.0¹⁴,¹⁶]hexadec-8-en-14-yl hexadeca-2,4,6-trienoate
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,4s,5r,9s,10s,13r,15r)-5,9-dimethyl-14-methylidene-15-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
3-{2-[(1r,4as,5r,8as)-5-({[(2r,3r,4s,5s,6r)-3-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-5h-furan-2-one
(2z,3e,5e,7e,9e,11e,13e)-2-(2,4-dimethylhexylidene)-14-{4-hydroxy-6-oxo-5-[(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]pyran-2-yl}-4-methyltetradeca-3,5,7,9,11,13-hexaenoic acid
(1r,2s,4r,6r,9r,10r,11r,14r,15r,18r)-6-[(5s)-5-(2-hydroxypropan-2-yl)-2-oxo-5h-furan-3-yl]-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-14-yl 3-methylbut-2-enoate
6-[5-(2-hydroxypropan-2-yl)-2-oxo-5h-furan-3-yl]-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-14-yl 3-methylbut-2-enoate
1,4,6,11,14-eudesmanepentol; (1α,4β,5β,6β,10α)-form,6-o-[beta-d-glucopyranosyl-(1→6)-beta-d-glucopyranoside]
{"Ingredient_id": "HBIN001333","Ingredient_name": "1,4,6,11,14-eudesmanepentol; (1\u03b1,4\u03b2,5\u03b2,6\u03b2,10\u03b1)-form,6-o-[beta-d-glucopyranosyl-(1\u21926)-beta-d-glucopyranoside]","Alias": "NA","Ingredient_formula": "C27H48O15","Ingredient_Smile": "NA","Ingredient_weight": "612.66","OB_score": "NA","CAS_id": "256528-96-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9536","PubChem_id": "NA","DrugBank_id": "NA"}